GlassScriptPhysician profile
Jarred Strickling
NPI 1861951824
$4,344.72
in general payments reported to CMS, 2019-2025
5 companies · $4,121 in 2025
The $4,121 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $110 · 2023: $114 · 2025: $4,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935 · Travel and Lodging: $1,837 · Education: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.85 |
| Travel and Lodging | $1,837.31 |
| Education | $462.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,014.37 | 2025 | Ingevity+, Farapulse, General - Therapies |
| Biotronik INC. | $491.05 | 2025 | Selectra, Solia |
| Biosense Webster, INC. | $358.55 | 2025 | Carto 3 |
| Medtronic, INC. | $257.07 | 2025 | Affera Mapping System |
| Novo Nordisk INC | $223.68 | 2022-2023 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarred Strickling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.